Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between doses

Nav

General Info

Geography

Massachusetts

United States of America (USA)

Time period covered

01/2001 - 12/2005

Data type

Scientific literature

Keywords

Diarrhea, Diarrheal diseases, Rotavirus

Citation

Authors

Goveia MG, Suprun L, Itzler RF, McFetridge R, Dallas MJ, Kuter BJ

Journal

Pediatr Infect Dis J

Volume

Issue

Pages

263-5

Publication year

2010

Suggested citation

Goveia MG, Suprun L, Itzler RF, McFetridge R, Dallas MJ, Kuter BJ. Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between doses. Pediatr Infect Dis J. 2010; 29(3): 263-5.

DOI

10.1097/INF.0b013e3181be6257

PMID

19949360

GHDx Entry last modified on: May 30, 2020

Header sites

Search form

Main menu

Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between doses

Nav